دورية أكاديمية
أعرض في EDS

A randomized controlled trial of shared decision-making treatment planning process to enhance shared decision-making in patients with MBC.

التفاصيل البيبلوغرافية
العنوان: A randomized controlled trial of shared decision-making treatment planning process to enhance shared decision-making in patients with MBC.
المؤلفون: Rocque GB; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA. grocque@uabmc.edu.; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA. grocque@uabmc.edu.; Division of Gerontology/Geriatrics/Palliative Care, Department of Medicine, University of Alabama at Birmingham, South, AL, 35294, USA. grocque@uabmc.edu., Eltoum N; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Caston NE; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Williams CP; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.; Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Oliver MM; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Moradi L; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Ingram S; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA., Azuero A; School of Nursing, University of Alabama at Birmingham, Birmingham, AL, USA., Pisu M; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.; Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Bhatia S; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA.
المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Aug; Vol. 206 (3), pp. 483-493. Date of Electronic Publication: 2024 Jun 10.
نوع المنشور: Journal Article; Randomized Controlled Trial
اللغة: English
بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
أسماء مطبوعة: Publication: Dordrecht : Kluwer Academic
Original Publication: The Hague ; Boston : M. Nijhoff, c1981-
مواضيع طبية MeSH: Breast Neoplasms*/psychology , Breast Neoplasms*/therapy , Decision Making, Shared* , Patient Participation*, Humans ; Female ; Middle Aged ; Aged ; Physician-Patient Relations ; Patient Preference ; Adult ; Patient Care Planning
مستخلص: Purpose: Opportunities exist for patients with metastatic breast cancer (MBC) to engage in shared decision-making (SDM). Presenting patient-reported data, including patient treatment preferences, to oncologists before or during a treatment plan decision may improve patient engagement in treatment decisions.
Methods: This randomized controlled trial evaluated the standard-of-care treatment planning process vs. a novel treatment planning process focused on SDM, which included oncologist review of patient-reported treatment preferences, prior to or during treatment decisions among women with MBC. The primary outcome was patient perception of shared decision-making. Secondary outcomes included patient activation, treatment satisfaction, physician perception of treatment decision-making, and use of treatment plans.
Results: Among the 109 evaluable patients from December 2018 to June 2022, 28% were Black and 12% lived in a highly disadvantaged neighborhood. Although not reaching statistical significance, patients in the intervention arm perceived SDM more often than patients in the control arm (63% vs. 59%; Cramer's V = 0.05; OR 1.19; 95% CI 0.55-2.57). Among patients in the intervention arm, 31% were at the highest level of patient activation compared to 19% of those in the control arm (V = 0.18). In 82% of decisions, the oncologist agreed that the patient-reported data helped them engage in SDM. In 45% of decision, they reported changing management due to patient-reported data.
Conclusions: Oncologist engagement in the treatment planning process, with oncologist review of patient-reported data, is a promising approach to improve patient participation in treatment decisions which should be tested in larger studies.
Trial Registration: NCT03806738.
(© 2024. The Author(s).)
References: Health Serv Res. 2004 Aug;39(4 Pt 1):1005-26. (PMID: 15230939)
Breast. 2021 Oct;59:232-238. (PMID: 34304064)
J Pain Symptom Manage. 2012 Apr;43(4):663-78. (PMID: 22464352)
Health Qual Life Outcomes. 2004 Feb 26;2:12. (PMID: 14987333)
Cancer. 2013 Jan 1;119(1):158-63. (PMID: 23197186)
BMJ. 2010 Mar 23;340:c869. (PMID: 20332511)
JAMA Oncol. 2020 Feb 1;6(2):196-204. (PMID: 31697365)
Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2203915119. (PMID: 35914161)
J Geriatr Oncol. 2020 Mar;11(2):203-211. (PMID: 31451439)
Clin Breast Cancer. 2021 Feb;21(1):37-46. (PMID: 32741667)
Oncologist. 2011;16(12):1800-5. (PMID: 22128118)
Can J Nurs Res. 1997 Fall;29(3):21-43. (PMID: 9505581)
J Palliat Care. 2019 Jan;34(1):29-31. (PMID: 30382006)
Qual Life Res. 2010 Apr;19(3):371-9. (PMID: 20146009)
J Clin Oncol. 2018 Mar 1;36(7):659-666. (PMID: 29364772)
J Geriatr Oncol. 2020 Nov;11(8):1324-1328. (PMID: 32732011)
BMC Public Health. 2013 Dec 12;13:1169. (PMID: 24330527)
Cancer. 2020 Aug 1;126(15):3534-3541. (PMID: 32426870)
JAMA. 2014 Jul 16;312(3):240-8. (PMID: 25027139)
Ann Oncol. 2010 Jun;21(6):1145-1151. (PMID: 19940010)
Oncologist. 2019 Oct;24(10):1313-1321. (PMID: 30872466)
Patient Educ Couns. 2017 Jul;100(7):1276-1279. (PMID: 28330715)
JCO Oncol Pract. 2022 Nov;18(11):737-741. (PMID: 36252157)
Health Qual Life Outcomes. 2022 May 21;20(1):82. (PMID: 35597948)
Cancer. 2013 Jan 1;119(1):164-72. (PMID: 23197335)
J Clin Oncol. 2016 Feb 20;34(6):557-65. (PMID: 26644527)
J Natl Compr Canc Netw. 2022 Jun;20(6):691-722. (PMID: 35714673)
JAMA Oncol. 2021 Nov 01;7(11):e214158. (PMID: 34591080)
J Oncol Pract. 2017 Aug;13(8):512-514. (PMID: 28613969)
Am J Manag Care. 2010 Sep;16(9):688-96. (PMID: 20873956)
Cancer. 2021 Feb 1;127(3):449-457. (PMID: 33108023)
J Natl Cancer Inst. 2023 Nov 8;115(11):1271-1277. (PMID: 37421403)
J Clin Oncol. 2006 Feb 20;24(6):904-9. (PMID: 16484700)
J Clin Oncol. 2004 Aug 1;22(15):3091-8. (PMID: 15284259)
JAMA. 2004 Jul 28;292(4):435-41. (PMID: 15280341)
Target Oncol. 2016 Jun;11(3):277-92. (PMID: 26677846)
Health Serv Res. 2005 Dec;40(6 Pt 1):1918-30. (PMID: 16336556)
JAMA. 2018 Jun 5;319(21):2223-2224. (PMID: 29872845)
J Clin Oncol. 2016 Nov 20;34(33):4047-4048. (PMID: 27551131)
J Racial Ethn Health Disparities. 2018 Feb;5(1):117-140. (PMID: 28275996)
J Clin Oncol. 2011 Mar 10;29(8):994-1000. (PMID: 21282546)
JCO Oncol Pract. 2022 May;18(5):e731-e739. (PMID: 34995081)
Am J Public Health. 2003 Jul;93(7):1137-43. (PMID: 12835199)
J Oncol Pract. 2012 Nov;8(6):e142-8. (PMID: 23598849)
معلومات مُعتمدة: MRSG- 17-051-01 -PCSM American Cancer Society
فهرسة مساهمة: Keywords: Metastatic breast cancer; Patient-reported data; Shared decision-making; Treatment planning
سلسلة جزيئية: ClinicalTrials.gov NCT03806738
تواريخ الأحداث: Date Created: 20240610 Date Completed: 20240626 Latest Revision: 20240629
رمز التحديث: 20240629
مُعرف محوري في PubMed: PMC11208240
DOI: 10.1007/s10549-024-07304-y
PMID: 38856885
قاعدة البيانات: MEDLINE
الوصف
تدمد:1573-7217
DOI:10.1007/s10549-024-07304-y